Valeo provides a mobile health platform for blood testing, health records, supplements, and at-home wellness services.
Founded in 2021 and based in Dubai, Valeo Wellbeing Technologies provides a mobile platform for booking home blood collection, receiving test results, and tracking health records. Its services include blood tests, IV therapies, and supplements. In March 2025, it raised USD 12 million in Series B funding led by Flintera, with Oraseya Capital and Eirad Group participating alongside returning investors Nuwa Capital, FJ Labs, Oryx, and Mindshift Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in